LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea · Delayed Price · Currency is KRW 1,293.00
+19.00 (1.49%)
Apr 3, 2026, 3:30 PM KST
LabGenomics Revenue
In the year 2025, LabGenomics had annual revenue of 88.16B KRW with 2.63% growth. LabGenomics had revenue of 20.92B in the quarter ending December 31, 2025, a decrease of -5.43%.
Revenue
88.16B
Revenue Growth
+2.63%
P/S Ratio
1.09
Revenue / Employee
620.85M
Employees
142
Market Cap
95.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 88.16B | 2.26B | 2.63% |
| Dec 31, 2024 | 85.90B | 14.82B | 20.85% |
| Dec 31, 2023 | 71.08B | -73.70B | -50.90% |
| Dec 31, 2022 | 144.77B | -57.63B | -28.47% |
| Dec 31, 2021 | 202.41B | 82.93B | 69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Osang Healthcare Co.,Ltd | 128.63B |
| DRTECH | 116.30B |
| Ray Co., Ltd. | 111.32B |
| Bio Plus | 90.90B |
| T&R Biofab | 26.97B |
| HASS Corp. | 16.59B |
| Sugentech | 9.42B |
| P&S Robotics | 8.55B |